First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia

Transfus Apher Sci. 2020 Oct;59(5):102866. doi: 10.1016/j.transci.2020.102866. Epub 2020 Jul 1.

Abstract

We present the case of a six-year-old girl with severe COVID-19, in whom SARS-CoV-2 was successfully eliminated after convalescent plasma transfusion. Children show a variable clinical course of COVID-19, from asymptomatic to critical. In our patient, we diagnosed COVID-19-associated aplastic anemia with severe pancytopenia. The correlation between SARS-CoV-2 infection with aplastic anemia remains unclear. At the beginning of the disease, we used antiviral drugs and immune modulators as therapy but without any positive results. After providing a transfusion of convalescent plasma, the elimination of SARS-CoV-2 was observed. We did not observe any adverse events of this treatment. The girl still has a diagnosis of aplastic anemia and requires specialist therapy.

Keywords: Children; Convalescent plasma; Pancytopenia; SARS-CoV-2; Transfusion.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic / etiology*
  • Anemia, Aplastic / immunology
  • Blood Component Transfusion*
  • COVID-19 / complications*
  • COVID-19 / immunology
  • COVID-19 / therapy*
  • COVID-19 Serotherapy
  • Child
  • Female
  • Humans
  • Immunization, Passive
  • SARS-CoV-2 / physiology